Medical Care

Global Myocardial Fibrosis Market Insights, Forecast to 2030

Myocardial fibrosis is an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts. Symptoms include chest pain, some abdominal swelling,nausea and fatigue.Myocardial fibrosis, also known as myocardial calcification, is the result of sustained myocardial fiber and/or repeated aggravation of myocardial ischemia and hypoxia caused by moderate to severe coronary atherosclerotic stenosis, leading to the progressive development of heart failure with IHD, or chronic ischemic heart disease
Market Analysis and Insights: Global Myocardial Fibrosis Market
The global Myocardial Fibrosis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Myocardial Fibrosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Myocardial Fibrosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Myocardial Fibrosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Myocardial Fibrosis include Merck, Evotec AG, Miragen Therapeutics, TRACON Pharmaceuticals, Daewoong Pharmaceutical, Galectin Therapeutics, GTx, Invivosciences and Lead Discovery Center, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Myocardial Fibrosis is widely used in various fields, such as Hospital, Clinics and Research Laboratories,, etc. Hospital provides greatest supports to the Myocardial Fibrosis industry development. In 2023, global % revenue of Myocardial Fibrosis went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Myocardial Fibrosis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Myocardial Fibrosis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Myocardial Fibrosis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Myocardial Fibrosis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Myocardial Fibrosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Myocardial Fibrosis revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Merck
Evotec AG
Miragen Therapeutics
TRACON Pharmaceuticals
Daewoong Pharmaceutical
Galectin Therapeutics
GTx
Invivosciences
Lead Discovery Center
MandalMed
Segment by Type
Small Molecule Therapeutic Modality
Protein Therapeutic Modality
Peptide Therapeutic Modality
Endoglin Antibody Therapeutic Modality
Stem Cell Therapeutic Modality
RNA Therapeutic Modality
Other
Segment by Application
Hospital
Clinics
Research Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Myocardial Fibrosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myocardial Fibrosis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Myocardial Fibrosis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myocardial Fibrosis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Small Molecule Therapeutic Modality
1.2.3 Protein Therapeutic Modality
1.2.4 Peptide Therapeutic Modality
1.2.5 Endoglin Antibody Therapeutic Modality
1.2.6 Stem Cell Therapeutic Modality
1.2.7 RNA Therapeutic Modality
1.2.8 Other
1.3 Market by Application
1.3.1 Global Myocardial Fibrosis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myocardial Fibrosis Market Perspective (2019-2030)
2.2 Global Myocardial Fibrosis Growth Trends by Region
2.2.1 Myocardial Fibrosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Myocardial Fibrosis Historic Market Size by Region (2019-2024)
2.2.3 Myocardial Fibrosis Forecasted Market Size by Region (2025-2030)
2.3 Myocardial Fibrosis Market Dynamics
2.3.1 Myocardial Fibrosis Industry Trends
2.3.2 Myocardial Fibrosis Market Drivers
2.3.3 Myocardial Fibrosis Market Challenges
2.3.4 Myocardial Fibrosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Myocardial Fibrosis by Players
3.1.1 Global Myocardial Fibrosis Revenue by Players (2019-2024)
3.1.2 Global Myocardial Fibrosis Revenue Market Share by Players (2019-2024)
3.2 Global Myocardial Fibrosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Myocardial Fibrosis, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Myocardial Fibrosis Market Concentration Ratio
3.4.1 Global Myocardial Fibrosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myocardial Fibrosis Revenue in 2023
3.5 Global Key Players of Myocardial Fibrosis Head office and Area Served
3.6 Global Key Players of Myocardial Fibrosis, Product and Application
3.7 Global Key Players of Myocardial Fibrosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myocardial Fibrosis Breakdown Data by Type
4.1 Global Myocardial Fibrosis Historic Market Size by Type (2019-2024)
4.2 Global Myocardial Fibrosis Forecasted Market Size by Type (2025-2030)
5 Myocardial Fibrosis Breakdown Data by Application
5.1 Global Myocardial Fibrosis Historic Market Size by Application (2019-2024)
5.2 Global Myocardial Fibrosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Myocardial Fibrosis Market Size (2019-2030)
6.2 North America Myocardial Fibrosis Market Size by Type
6.2.1 North America Myocardial Fibrosis Market Size by Type (2019-2024)
6.2.2 North America Myocardial Fibrosis Market Size by Type (2025-2030)
6.2.3 North America Myocardial Fibrosis Market Share by Type (2019-2030)
6.3 North America Myocardial Fibrosis Market Size by Application
6.3.1 North America Myocardial Fibrosis Market Size by Application (2019-2024)
6.3.2 North America Myocardial Fibrosis Market Size by Application (2025-2030)
6.3.3 North America Myocardial Fibrosis Market Share by Application (2019-2030)
6.4 North America Myocardial Fibrosis Market Size by Country
6.4.1 North America Myocardial Fibrosis Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Myocardial Fibrosis Market Size by Country (2019-2024)
6.4.3 North America Myocardial Fibrosis Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Myocardial Fibrosis Market Size (2019-2030)
7.2 Europe Myocardial Fibrosis Market Size by Type
7.2.1 Europe Myocardial Fibrosis Market Size by Type (2019-2024)
7.2.2 Europe Myocardial Fibrosis Market Size by Type (2025-2030)
7.2.3 Europe Myocardial Fibrosis Market Share by Type (2019-2030)
7.3 Europe Myocardial Fibrosis Market Size by Application
7.3.1 Europe Myocardial Fibrosis Market Size by Application (2019-2024)
7.3.2 Europe Myocardial Fibrosis Market Size by Application (2025-2030)
7.3.3 Europe Myocardial Fibrosis Market Share by Application (2019-2030)
7.4 Europe Myocardial Fibrosis Market Size by Country
7.4.1 Europe Myocardial Fibrosis Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Myocardial Fibrosis Market Size by Country (2019-2024)
7.4.3 Europe Myocardial Fibrosis Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Myocardial Fibrosis Market Size (2019-2030)
8.2 China Myocardial Fibrosis Market Size by Type
8.2.1 China Myocardial Fibrosis Market Size by Type (2019-2024)
8.2.2 China Myocardial Fibrosis Market Size by Type (2025-2030)
8.2.3 China Myocardial Fibrosis Market Share by Type (2019-2030)
8.3 China Myocardial Fibrosis Market Size by Application
8.3.1 China Myocardial Fibrosis Market Size by Application (2019-2024)
8.3.2 China Myocardial Fibrosis Market Size by Application (2025-2030)
8.3.3 China Myocardial Fibrosis Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Myocardial Fibrosis Market Size (2019-2030)
9.2 Asia Myocardial Fibrosis Market Size by Type
9.2.1 Asia Myocardial Fibrosis Market Size by Type (2019-2024)
9.2.2 Asia Myocardial Fibrosis Market Size by Type (2025-2030)
9.2.3 Asia Myocardial Fibrosis Market Share by Type (2019-2030)
9.3 Asia Myocardial Fibrosis Market Size by Application
9.3.1 Asia Myocardial Fibrosis Market Size by Application (2019-2024)
9.3.2 Asia Myocardial Fibrosis Market Size by Application (2025-2030)
9.3.3 Asia Myocardial Fibrosis Market Share by Application (2019-2030)
9.4 Asia Myocardial Fibrosis Market Size by Region
9.4.1 Asia Myocardial Fibrosis Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Myocardial Fibrosis Market Size by Region (2019-2024)
9.4.3 Asia Myocardial Fibrosis Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Myocardial Fibrosis Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Myocardial Fibrosis Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Myocardial Fibrosis Introduction
11.1.4 Merck Revenue in Myocardial Fibrosis Business (2019-2024)
11.1.5 Merck Recent Developments
11.2 Evotec AG
11.2.1 Evotec AG Company Details
11.2.2 Evotec AG Business Overview
11.2.3 Evotec AG Myocardial Fibrosis Introduction
11.2.4 Evotec AG Revenue in Myocardial Fibrosis Business (2019-2024)
11.2.5 Evotec AG Recent Developments
11.3 Miragen Therapeutics
11.3.1 Miragen Therapeutics Company Details
11.3.2 Miragen Therapeutics Business Overview
11.3.3 Miragen Therapeutics Myocardial Fibrosis Introduction
11.3.4 Miragen Therapeutics Revenue in Myocardial Fibrosis Business (2019-2024)
11.3.5 Miragen Therapeutics Recent Developments
11.4 TRACON Pharmaceuticals
11.4.1 TRACON Pharmaceuticals Company Details
11.4.2 TRACON Pharmaceuticals Business Overview
11.4.3 TRACON Pharmaceuticals Myocardial Fibrosis Introduction
11.4.4 TRACON Pharmaceuticals Revenue in Myocardial Fibrosis Business (2019-2024)
11.4.5 TRACON Pharmaceuticals Recent Developments
11.5 Daewoong Pharmaceutical
11.5.1 Daewoong Pharmaceutical Company Details
11.5.2 Daewoong Pharmaceutical Business Overview
11.5.3 Daewoong Pharmaceutical Myocardial Fibrosis Introduction
11.5.4 Daewoong Pharmaceutical Revenue in Myocardial Fibrosis Business (2019-2024)
11.5.5 Daewoong Pharmaceutical Recent Developments
11.6 Galectin Therapeutics
11.6.1 Galectin Therapeutics Company Details
11.6.2 Galectin Therapeutics Business Overview
11.6.3 Galectin Therapeutics Myocardial Fibrosis Introduction
11.6.4 Galectin Therapeutics Revenue in Myocardial Fibrosis Business (2019-2024)
11.6.5 Galectin Therapeutics Recent Developments
11.7 GTx
11.7.1 GTx Company Details
11.7.2 GTx Business Overview
11.7.3 GTx Myocardial Fibrosis Introduction
11.7.4 GTx Revenue in Myocardial Fibrosis Business (2019-2024)
11.7.5 GTx Recent Developments
11.8 Invivosciences
11.8.1 Invivosciences Company Details
11.8.2 Invivosciences Business Overview
11.8.3 Invivosciences Myocardial Fibrosis Introduction
11.8.4 Invivosciences Revenue in Myocardial Fibrosis Business (2019-2024)
11.8.5 Invivosciences Recent Developments
11.9 Lead Discovery Center
11.9.1 Lead Discovery Center Company Details
11.9.2 Lead Discovery Center Business Overview
11.9.3 Lead Discovery Center Myocardial Fibrosis Introduction
11.9.4 Lead Discovery Center Revenue in Myocardial Fibrosis Business (2019-2024)
11.9.5 Lead Discovery Center Recent Developments
11.10 MandalMed
11.10.1 MandalMed Company Details
11.10.2 MandalMed Business Overview
11.10.3 MandalMed Myocardial Fibrosis Introduction
11.10.4 MandalMed Revenue in Myocardial Fibrosis Business (2019-2024)
11.10.5 MandalMed Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Myocardial Fibrosis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecule Therapeutic Modality
Table 3. Key Players of Protein Therapeutic Modality
Table 4. Key Players of Peptide Therapeutic Modality
Table 5. Key Players of Endoglin Antibody Therapeutic Modality
Table 6. Key Players of Stem Cell Therapeutic Modality
Table 7. Key Players of RNA Therapeutic Modality
Table 8. Key Players of Other
Table 9. Global Myocardial Fibrosis Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 10. Global Myocardial Fibrosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Myocardial Fibrosis Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Myocardial Fibrosis Market Share by Region (2019-2024)
Table 13. Global Myocardial Fibrosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Myocardial Fibrosis Market Share by Region (2025-2030)
Table 15. Myocardial Fibrosis Market Trends
Table 16. Myocardial Fibrosis Market Drivers
Table 17. Myocardial Fibrosis Market Challenges
Table 18. Myocardial Fibrosis Market Restraints
Table 19. Global Myocardial Fibrosis Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Myocardial Fibrosis Revenue Share by Players (2019-2024)
Table 21. Global Top Myocardial Fibrosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myocardial Fibrosis as of 2023)
Table 22. Global Myocardial Fibrosis Industry Ranking 2022 VS 2023 VS 2024
Table 23. Global 5 Largest Players Market Share by Myocardial Fibrosis Revenue (CR5 and HHI) & (2019-2024)
Table 24. Global Key Players of Myocardial Fibrosis, Headquarters and Area Served
Table 25. Global Key Players of Myocardial Fibrosis, Product and Application
Table 26. Global Key Players of Myocardial Fibrosis, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Myocardial Fibrosis Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Myocardial Fibrosis Revenue Market Share by Type (2019-2024)
Table 30. Global Myocardial Fibrosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Myocardial Fibrosis Revenue Market Share by Type (2025-2030)
Table 32. Global Myocardial Fibrosis Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Myocardial Fibrosis Revenue Share by Application (2019-2024)
Table 34. Global Myocardial Fibrosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Myocardial Fibrosis Revenue Share by Application (2025-2030)
Table 36. North America Myocardial Fibrosis Market Size by Type (2019-2024) & (US$ Million)
Table 37. North America Myocardial Fibrosis Market Size by Type (2025-2030) & (US$ Million)
Table 38. North America Myocardial Fibrosis Market Size by Application (2019-2024) & (US$ Million)
Table 39. North America Myocardial Fibrosis Market Size by Application (2025-2030) & (US$ Million)
Table 40. North America Myocardial Fibrosis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. North America Myocardial Fibrosis Market Size by Country (2019-2024) & (US$ Million)
Table 42. North America Myocardial Fibrosis Market Size by Country (2025-2030) & (US$ Million)
Table 43. Europe Myocardial Fibrosis Market Size by Type (2019-2024) & (US$ Million)
Table 44. Europe Myocardial Fibrosis Market Size by Type (2025-2030) & (US$ Million)
Table 45. Europe Myocardial Fibrosis Market Size by Application (2019-2024) & (US$ Million)
Table 46. Europe Myocardial Fibrosis Market Size by Application (2025-2030) & (US$ Million)
Table 47. Europe Myocardial Fibrosis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Europe Myocardial Fibrosis Market Size by Country (2019-2024) & (US$ Million)
Table 49. Europe Myocardial Fibrosis Market Size by Country (2025-2030) & (US$ Million)
Table 50. China Myocardial Fibrosis Market Size by Type (2019-2024) & (US$ Million)
Table 51. China Myocardial Fibrosis Market Size by Type (2025-2030) & (US$ Million)
Table 52. China Myocardial Fibrosis Market Size by Application (2019-2024) & (US$ Million)
Table 53. China Myocardial Fibrosis Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Myocardial Fibrosis Market Size by Type (2019-2024) & (US$ Million)
Table 55. Asia Myocardial Fibrosis Market Size by Type (2025-2030) & (US$ Million)
Table 56. Asia Myocardial Fibrosis Market Size by Application (2019-2024) & (US$ Million)
Table 57. Asia Myocardial Fibrosis Market Size by Application (2025-2030) & (US$ Million)
Table 58. Asia Myocardial Fibrosis Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 59. Asia Myocardial Fibrosis Market Size by Region (2019-2024) & (US$ Million)
Table 60. Asia Myocardial Fibrosis Market Size by Region (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Type (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Type (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Application (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Application (2025-2030) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Myocardial Fibrosis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 66. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Country (2019-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size by Country (2025-2030) & (US$ Million)
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Myocardial Fibrosis Product
Table 71. Merck Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 72. Merck Recent Developments
Table 73. Evotec AG Company Details
Table 74. Evotec AG Business Overview
Table 75. Evotec AG Myocardial Fibrosis Product
Table 76. Evotec AG Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 77. Evotec AG Recent Developments
Table 78. Miragen Therapeutics Company Details
Table 79. Miragen Therapeutics Business Overview
Table 80. Miragen Therapeutics Myocardial Fibrosis Product
Table 81. Miragen Therapeutics Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 82. Miragen Therapeutics Recent Developments
Table 83. TRACON Pharmaceuticals Company Details
Table 84. TRACON Pharmaceuticals Business Overview
Table 85. TRACON Pharmaceuticals Myocardial Fibrosis Product
Table 86. TRACON Pharmaceuticals Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 87. TRACON Pharmaceuticals Recent Developments
Table 88. Daewoong Pharmaceutical Company Details
Table 89. Daewoong Pharmaceutical Business Overview
Table 90. Daewoong Pharmaceutical Myocardial Fibrosis Product
Table 91. Daewoong Pharmaceutical Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 92. Daewoong Pharmaceutical Recent Developments
Table 93. Galectin Therapeutics Company Details
Table 94. Galectin Therapeutics Business Overview
Table 95. Galectin Therapeutics Myocardial Fibrosis Product
Table 96. Galectin Therapeutics Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 97. Galectin Therapeutics Recent Developments
Table 98. GTx Company Details
Table 99. GTx Business Overview
Table 100. GTx Myocardial Fibrosis Product
Table 101. GTx Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 102. GTx Recent Developments
Table 103. Invivosciences Company Details
Table 104. Invivosciences Business Overview
Table 105. Invivosciences Myocardial Fibrosis Product
Table 106. Invivosciences Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 107. Invivosciences Recent Developments
Table 108. Lead Discovery Center Company Details
Table 109. Lead Discovery Center Business Overview
Table 110. Lead Discovery Center Myocardial Fibrosis Product
Table 111. Lead Discovery Center Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 112. Lead Discovery Center Recent Developments
Table 113. MandalMed Company Details
Table 114. MandalMed Business Overview
Table 115. MandalMed Myocardial Fibrosis Product
Table 116. MandalMed Revenue in Myocardial Fibrosis Business (2019-2024) & (US$ Million)
Table 117. MandalMed Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Myocardial Fibrosis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Myocardial Fibrosis Market Share by Type: 2023 VS 2030
Figure 3. Small Molecule Therapeutic Modality Features
Figure 4. Protein Therapeutic Modality Features
Figure 5. Peptide Therapeutic Modality Features
Figure 6. Endoglin Antibody Therapeutic Modality Features
Figure 7. Stem Cell Therapeutic Modality Features
Figure 8. RNA Therapeutic Modality Features
Figure 9. Other Features
Figure 10. Global Myocardial Fibrosis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Myocardial Fibrosis Market Share by Application: 2023 VS 2030
Figure 12. Hospital Case Studies
Figure 13. Clinics Case Studies
Figure 14. Research Laboratories Case Studies
Figure 15. Myocardial Fibrosis Report Years Considered
Figure 16. Global Myocardial Fibrosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Myocardial Fibrosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Myocardial Fibrosis Market Share by Region: 2023 VS 2030
Figure 19. Global Myocardial Fibrosis Market Share by Players in 2023
Figure 20. Global Top Myocardial Fibrosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myocardial Fibrosis as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Myocardial Fibrosis Revenue in 2023
Figure 22. North America Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Myocardial Fibrosis Market Share by Type (2019-2030)
Figure 24. North America Myocardial Fibrosis Market Share by Application (2019-2030)
Figure 25. North America Myocardial Fibrosis Market Share by Country (2019-2030)
Figure 26. United States Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Myocardial Fibrosis Market Size YoY (2019-2030) & (US$ Million)
Figure 29. Europe Myocardial Fibrosis Market Share by Type (2019-2030)
Figure 30. Europe Myocardial Fibrosis Market Share by Application (2019-2030)
Figure 31. Europe Myocardial Fibrosis Market Share by Country (2019-2030)
Figure 32. Germany Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. France Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. U.K. Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Italy Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Russia Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Nordic Countries Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. China Myocardial Fibrosis Market Size YoY (2019-2030) & (US$ Million)
Figure 39. China Myocardial Fibrosis Market Share by Type (2019-2030)
Figure 40. China Myocardial Fibrosis Market Share by Application (2019-2030)
Figure 41. Asia Myocardial Fibrosis Market Size YoY (2019-2030) & (US$ Million)
Figure 42. Asia Myocardial Fibrosis Market Share by Type (2019-2030)
Figure 43. Asia Myocardial Fibrosis Market Share by Application (2019-2030)
Figure 44. Asia Myocardial Fibrosis Market Share by Region (2019-2030)
Figure 45. Japan Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. South Korea Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. China Taiwan Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. India Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Australia Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Myocardial Fibrosis Market Size YoY (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Myocardial Fibrosis Market Share by Type (2019-2030)
Figure 53. Middle East, Africa, and Latin America Myocardial Fibrosis Market Share by Application (2019-2030)
Figure 54. Middle East, Africa, and Latin America Myocardial Fibrosis Market Share by Country (2019-2030)
Figure 55. Brazil Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Mexico Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Turkey Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Israel Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. GCC Countries Myocardial Fibrosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. Merck Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 62. Evotec AG Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 63. Miragen Therapeutics Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 64. TRACON Pharmaceuticals Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 65. Daewoong Pharmaceutical Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 66. Galectin Therapeutics Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 67. GTx Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 68. Invivosciences Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 69. Lead Discovery Center Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 70. MandalMed Revenue Growth Rate in Myocardial Fibrosis Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies